How should I manage a patient with blood pressure >180 mmHg who is currently taking hydralazine 25 mg three times daily and losartan 20 mg daily?

Optimize the Current Regimen and Add a Thiazide Diuretic

Your patient's blood pressure remains severely elevated (>180 mmHg) on suboptimal doses of both medications—you need to increase losartan to at least 100 mg daily and add hydrochlorothiazide 12.5-25 mg rather than continuing hydralazine three times daily. 1

Why This Current Regimen Is Failing

Your patient is on losartan 20 mg daily, which is far below the therapeutic range. The FDA-approved dosing for hypertension starts at 50 mg daily and can be titrated to 100 mg daily as needed for blood pressure control 1. At 20 mg, you're providing essentially subtherapeutic dosing of an angiotensin receptor blocker.

The hydralazine 25 mg three times daily is problematic for multiple reasons:

• Hydralazine is NOT a first-line agent for chronic hypertension management 2
• It's relegated to resistant hypertension as a fourth or fifth-line option after optimizing standard therapy 2
• The drug causes myocardial stimulation, can precipitate anginal attacks and myocardial infarction, and produces a "hyperdynamic" circulation 3
• Multiple studies demonstrate that IV hydralazine is frequently misused in hospitalized patients for non-emergent hypertension, causing hypotension and other adverse events 4, 5, 6, 7
• While your patient is on oral hydralazine, the same concerns about inappropriate use apply—it's being used as a primary agent when better options exist

The Correct Approach

Step 1: Optimize Losartan Dosing

• Increase losartan from 20 mg to 100 mg once daily 1
• This is the maximum approved dose and provides optimal renin-angiotensin system blockade
• Studies show losartan 100 mg is effective and well-tolerated in high-risk patients 8

Step 2: Add Hydrochlorothiazide

• Add hydrochlorothiazide 12.5-25 mg once daily 9, 2
• The combination of losartan with a thiazide diuretic is guideline-recommended for uncontrolled hypertension 2
• Losartan 100 mg + HCTZ 25 mg produces additive blood pressure reduction of approximately 24/12 mmHg 10
• The fixed-dose combination of losartan 50 mg + HCTZ 12.5 mg achieved excellent/good response in 78% of patients 11
• Higher doses (losartan 150 mg + HCTZ 37.5 mg) can be considered if needed, with additional 5.6 mmHg systolic reduction 10

Step 3: Discontinue Hydralazine

• Taper and discontinue the hydralazine once the optimized regimen is established
• Hydralazine should only be considered in resistant hypertension after failing optimal doses of a calcium channel blocker, RAS blocker, and thiazide diuretic, plus spironolactone 2

If Blood Pressure Remains Uncontrolled

After optimizing losartan + HCTZ, if BP remains >180 mmHg:

1. Add a calcium channel blocker (amlodipine 5-10 mg daily) as third-line therapy 2
2. Add spironolactone 25 mg daily if still uncontrolled on three agents (this defines resistant hypertension) 2
3. Only then consider adding hydralazine as a fourth or fifth-line agent 2

Critical Pitfalls to Avoid

• Don't use IV or oral hydralazine for asymptomatic blood pressure elevations—it causes unpredictable BP drops and hypotension 4, 12, 7
• Don't continue subtherapeutic dosing—losartan 20 mg is inadequate; you must reach 100 mg 1
• Don't add multiple agents without optimizing existing ones first—this is a common error leading to polypharmacy without benefit 5
• Reinforce lifestyle modifications including sodium restriction, which is particularly important for resistant hypertension 2

Monitoring

• Recheck blood pressure in 2-4 weeks after medication adjustment
• Monitor serum potassium and creatinine after adding HCTZ and increasing losartan 1
• If using higher HCTZ doses (>25 mg), monitor for metabolic effects, though studies show losartan/HCTZ combinations don't cause deleterious metabolic changes 10